Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 
 
 

Nanion Technologies and Assay.Works partner up
February 2020
SHARING OPTIONS:

MUNICH, Germany—Nanion Technologies, a leading provider of automated electrophysiology systems, recently announced a partnership with Assay.Works, experts in assay development and high-throughput screening, who will be providing SURFE²R 96SE assays for membrane transporter research.
 
Membrane transport proteins, which enable active and secondary active transport of ions and solutes across the membrane, are important drug targets but may also be involved in unwanted side effects. Nanion’s SURFE²R platform employs label-free, SSM-based electrophysiology to resolve small currents of transporters and pumps.
 
Said Dr. Ralf Schwandner, CEO of Assay.Works: “We are excited to deepen our long-standing relationship with the electrophysiology experts at Nanion. Their SURFE²R platform perfectly fits our mission to develop and apply predictive and scalable assays for therapeutics discovery.”

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.